Toxoplasmosis in HIV-positive individuals is well-studied and has a codified management protocol, which is not the case for other immunodeficiencies, except for recent recommendations in the context of hematopoietic stem cell transplantation. A description of this population is necessary to estimate the number of patients affected and to define their specific management (diagnosis, treatment, prevention).
Study Type
OBSERVATIONAL
Enrollment
30
Service d'immunologie clinique - Hôpitaux Universitaires de Strasbourg
Strasbourg, France
RECRUITINGOverall patient survival rates
Time frame: Up to 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.